Department of Biology, College of Science, University of Jeddah, Jeddah, Saudi Arabia.
Department of Biological Sciences, Faculty of Science, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Sci Rep. 2024 Apr 17;14(1):8902. doi: 10.1038/s41598-024-58536-3.
Colorectal cancer (CRC) is the third most common cancer affecting people. The discovery of new, non-invasive, specific, and sensitive molecular biomarkers for CRC may assist in the diagnosis and support therapeutic decision making. Exosomal miRNAs have been demonstrated in carcinogenesis and CRC development, which makes these miRNAs strong biomarkers for CRC. Deep sequencing allows a robust high-throughput informatics investigation of the types and abundance of exosomal miRNAs. Thus, exosomal miRNAs can be efficiently examined as diagnostic biomarkers for disease screening. In the present study, a number of 660 mature miRNAs were detected in patients diagnosed with CRC at different stages. Of which, 29 miRNAs were differentially expressed in CRC patients compared with healthy controls. Twenty-nine miRNAs with high abundance levels were further selected for subsequent analysis. These miRNAs were either highly up-regulated (e.g., let-7a-5p, let-7c-5p, let-7f-5p, let-7d-3p, miR-423-5p, miR-3184-5p, and miR-584) or down-regulated (e.g., miR-30a-5p, miR-99-5p, miR-150-5p, miR-26-5p and miR-204-5p). These miRNAs influence critical genes in CRC, leading to either tumor growth or suppression. Most of the reported diagnostic exosomal miRNAs were shown to be circulating in blood serum. The latter is a novel miRNA that was found in exosomal profile of blood serum. Some of the predicted target genes of highly expressed miRNAs participate in several cancer pathways, including CRC pathway. These target genes include tumor suppressor genes, oncogenes and DNA repair genes. Main focus was given to multiple critical signaling cross-talking pathways including transforming growth factor β (TGFβ) signaling pathways that are directly linked to CRC. In conclusion, we recommend further analysis in order to experimentally confirm exact relationships between selected differentially expressed miRNAs and their predicted target genes and downstream functional consequences.
结直肠癌(CRC)是影响人类的第三大常见癌症。发现新的、非侵入性的、特异性和敏感性的 CRC 分子生物标志物可能有助于诊断和支持治疗决策。外泌体 miRNA 已被证明在致癌作用和 CRC 发展中发挥作用,这使得这些 miRNA 成为 CRC 的强生物标志物。深度测序允许对 exosomal miRNAs 的类型和丰度进行稳健的高通量信息学研究。因此,exosomal miRNAs 可以作为疾病筛查的有效诊断生物标志物进行检查。在本研究中,在不同阶段诊断为 CRC 的患者中检测到了 660 种成熟的 miRNA。其中,与健康对照组相比,CRC 患者中有 29 种 miRNA 表达差异。进一步选择 29 种高丰度的 miRNA 进行后续分析。这些 miRNA 要么高度上调(例如,let-7a-5p、let-7c-5p、let-7f-5p、let-7d-3p、miR-423-5p、miR-3184-5p 和 miR-584),要么下调(例如,miR-30a-5p、miR-99-5p、miR-150-5p、miR-26-5p 和 miR-204-5p)。这些 miRNA 影响 CRC 中的关键基因,导致肿瘤生长或抑制。大多数报道的诊断性 exosomal miRNAs 被证明在血清中循环。后者是在血清 exosomal 谱中发现的新型 miRNA。高度表达 miRNA 的一些预测靶基因参与包括 CRC 途径在内的几种癌症途径。这些靶基因包括肿瘤抑制基因、癌基因和 DNA 修复基因。重点关注多个关键信号转导交叉对话途径,包括与 CRC 直接相关的转化生长因子β(TGFβ)信号途径。总之,我们建议进一步分析,以实验证实所选差异表达 miRNA 与其预测靶基因及其下游功能后果之间的确切关系。